Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Ori Biotech
Ori Biotech
Activities:
Pharmaceutical
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Graphs and graph data science in drug discovery
Life sciences data expert Dr Alexander Jarasch discusses what work being done at the Institut de Recherches Servier can teach us about using modern data technologies for early...
The (r)evolution of biocatalysis in API synthesis
Explore Farmhispania Group’s enzyme toolbox to develop cost-effective, green-by-design synthetic routes for the cGMP production of your small-molecule NCEs
From batch to continuous chemistry to continuous processing
The main challenge in many flow reactors lies in achieving a smooth and continuous flow within microchannels. Dec Group focuses on effectively transporting solid materials and...
PCI Pharma Services commences installation of sterile fill-finish and lyophilisation line
The Bedford, NH site will advance PCI's manufacturing capabilities with twin lyophilisers and a large-scale isolator filling line, making this the third sterile fill-finish...
Upcoming event
ASGCT Annual Meeting 2024
7-11 May, 2024 | Meeting | Portland, OR
See all
Related Content
Finance
Ori Biotech expands board of directors and scientific advisory board
Dr Annalisa Jenkins will join Ori’s board of directors, and Robert Preti will join its scientific advisory board
Finance
Ori Biotech appoints senior management roles
Stuart Milne and Kevin Gordon will join the company as CTO and Chief Data & Operating Officer respectively
Finance
Ori Biotech selected to join CGT consortium
The consortium has identified the development of process analytical technology as critical to the success of the industry
Manufacturing
Ori Biotech and Vineti collaborate on digital platform for CGTs
This partnership follows on from Ori’s $30 m Series A funding round in 2020, and Vineti’s release of its PTM Essentials solution for advanced therapy clinical trials
Finance
ATMPS and Ori Biotech collaborate on an integrated digital platform
The non-exclusive partnership will result in the integration of Ori’s proprietary CGT manufacturing platform’s data architecture with ATMPS’ Hataali secure data sharing platform
Finance
Ori Biotech completes $30m series A funding round
The Series A investor syndicate was led by the life sciences investment team at Northpond Ventures alongside Octopus Ventures
Pharmaceutical
Ori Biotech partners to test novel cell therapy manufacturing platform
Achilles Therapeutics has agreed to test Ori’s manufacturing platform in its proprietary clonal neoantigen T-cell (cNeT) therapy manufacturing process
Subscribe now